United States · Bill · HR
H.R. 6801 (115th)
RaD Fund Act of 2018
Introduced
13 September 2018
Last action
—
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Rare Disease Fund Act of 2018 or the RaD Fund Act of 2018 This bill requires the Department of the Treasury to organize the Rare Disease Therapeutics Corporation to purchase rights to, fund the development of, and sell ownership interests in drugs, biological products, and medical devices for rare diseases.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 13 September 2018
Introduced in House (PDF)
Introduced in House · EN · 13 September 2018
Introduced in House
summary · EN · 13 September 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/house-bill/6801
- Open data entity: https://api.congress.gov/v3/bill/115/hr/6801